PRASCEND® (pergolide mesylate) Offers Great Value

Because PPID is not a curable disease, daily lifelong therapy is needed to treat the clinical signs of PPID and minimize the secondary complications often associated with the disease. The good news for your clients is that for about the cost of a cup of coffee per day, there is a solution that will help manage the disease and return their horses to normal.

FDA-approved as safe and effective

PRASCEND controls the clinical signs of PPID, which cause pain and discomfort. What’s more, PRASCEND offers you and your clients the reassurance of specific FDA approval for use in horses to manage PPID. Efficacy and safety were shown in scientifically rigorous field trials used to obtain product licensing.

Helps avoid future treatment costs

PRASCEND is indicated to control signs associated with PPID. By controlling these clinical signs, horse owners avoid some of the potential expenses that might be incurred as a result of untreated PPID. Problems may develop as untreated PPID progresses, such as dental disease, chronic infections, recurring or chronic laminitis, or shaggy hair coats that require management, are potentially expensive to treat—not to mention uncomfortable for the horse.

Easy to use

Conveniently packaged, scored PRASCEND tablets have a validated shelf life and remain at a consistent, effective strength through their noted expiration dates. And the tablets are easy for your horse owners to administer. PRASCEND delivers the reassurance of FDA approval and consistency in dosing. For a small investment per day, your clients can get their horses back to their old selves again by giving a proven safe, stable, and effective tablet that’s easy to include in their normal feeding routine.

Human Warnings: Not for use in humans. Pregnant or lactating women should wear gloves when administering this product. It has been reported that pergolide tablets may cause eye irritation, an irritating smell, or headache when Prascend Tablets are split or crushed. Prascend Tablets should not be crushed due to the potential for increased human exposure and care should be taken to minimize exposure when splitting tablets. Consult a physician in case of accidental ingestion by humans.

More value… free diagnostic tools and educational materials

We know that the effective management of PPID is about more than the quality and reliability of the pergolide you prescribe. It's also about support. Boehringer Ingelheim supplies materials to help you better diagnose, treat, and manage PPID for your clients. We also provide educational materials for your clients that explain what PPID is, clinical signs to watch for in their horses, and the difference treatment with PRASCEND can make in their horses' lives.

When you prescribe PRASCEND, you’re helping reduce and control the consequences of PPID for your patients and clients—that’s a lot of added value. Click here to access free diagnostic and educational resources for veterinarians.

Important safety information

PRASCEND is for use in horses only. Treatment with PRASCEND has been observed to cause inappetance, with most cases being transient. Weight loss, lethargy, and behavioral changes may be observed in some horses. If severe, a temporary reduction of dose may be necessary. PRASCEND has not been evaluated in breeding, pregnant, or lactating animals. As PRASCEND is a dopamine agonist, it may interfere with reproductive hormones involved in these groups of animals. The concurrent use of dopamine antagonists should be avoided since these agents may diminish the effectiveness of PRASCEND. PRASCEND should not be used in horses with hypersensitivity to pergolide mesylate or other ergot derivatives. Refer to the package insert for complete product information.

References:

  1. PRASCEND®(pergolide mesylate) [package insert]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2011.
  2. PRASCEND®(pergolide mesylate) [Freedom of Information Summary]. St Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2011.